You have 9 free searches left this month | for more free features.

Herceptin

Showing 1 - 25 of 678

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metastatic Breast Cancer, Metastatic Gastric Cancer Trial in Changchun (Trastuzumab for injection, Herceptin)

Completed
  • Metastatic Breast Cancer
  • Metastatic Gastric Cancer
  • Trastuzumab for injection
  • Herceptin
  • Changchun, Jilin, China
    Affiliated Hospital of Changchun University of Traditional Chine
Mar 1, 2023

Her 2 Positive Breast Cancer, Breast Cancer Female, Breast Cancer Metastatic Trial in Boston (Sacituzumab Govitecan,

Not yet recruiting
  • Her 2 Positive Breast Cancer
  • +2 more
  • Sacituzumab Govitecan
  • +2 more
  • Boston, Massachusetts
  • +1 more
Oct 25, 2023

Gastric Cancer Trial in Beijing (RC48-ADC, Herceptin, Toripalimab)

Not yet recruiting
  • Gastric Cancer
  • Beijing, China
    Beijing Cancer Hospital
Aug 7, 2023

Breast Cancer Trial in Beijing (QL1701, Herceptin®, Docetaxel)

Active, not recruiting
  • Breast Cancer
  • Beijing, China
    Cancer Hospital,Chinese Academy of Medical Sciences
Nov 18, 2022

Breast Cancer Trial in Italy, Switzerland (Herceptin™ (Her), Herceptin™ (Her) + chemo)

Active, not recruiting
  • Breast Cancer
  • Herceptin™ (Her)
  • Herceptin™ (Her) + chemo
  • Milan, Italy
  • +16 more
Mar 18, 2022

HER2-positive Breast Cancer Trial (Paclitaxel + Trastuzumab, Trastuzumab)

Not yet recruiting
  • HER2-positive Breast Cancer
  • (no location specified)
May 24, 2022

Malignant Solid Tumor Trial in Philadelphia (Biopsy, Biospecimen Collection, Echocardiography)

Active, not recruiting
  • Malignant Solid Neoplasm
  • Biopsy
  • +5 more
  • Philadelphia, Pennsylvania
    ECOG-ACRIN Cancer Research Group
Nov 15, 2023

HER2 Positive Breast Cancer Trial in Worldwide (HD201, Herceptin, Docetaxel)

Completed
  • HER2 Positive Breast Cancer
  • Minsk, Belarus
  • +14 more
Apr 21, 2022

GastroEsophageal Cancer, Gastric Cancer Trial in Tampa (Neratinib, Trastuzumab, Oxaliplatin)

Recruiting
  • GastroEsophageal Cancer
  • Gastric Cancer
  • Tampa, Florida
    Moffitt Cancer Center
Oct 25, 2023

Breast Cancer Trial in United States (Lapatinib, Letrozole, Trastuzumab)

Active, not recruiting
  • Breast Cancer
  • Birmingham, Alabama
  • +7 more
May 15, 2022

Healthy Volunteers Trial in Brisbane (HD201, EU-Herceptin, US-Herceptin)

Completed
  • Healthy Volunteers
  • Brisbane, Australia
    Q Pharm
Apr 17, 2021

Breast Tumors, Breast Cancer, Breast Tumors Trial in United States (Standard Therapy, AMG 386 with or without Trastuzumab, AMG

Recruiting
  • Breast Neoplasms
  • +10 more
  • Standard Therapy
  • +32 more
  • Birmingham, Alabama
  • +35 more
Nov 17, 2022

Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Rectal Adenocarcinoma Trial in Scottsdale,

Not yet recruiting
  • Metastatic Colon Adenocarcinoma
  • +5 more
  • Trastuzumab
  • +2 more
  • Scottsdale, Arizona
  • +2 more
Jan 31, 2023

HER2 Positive Breast Carcinoma, Recurrent Breast Carcinoma, Stage III Breast Cancer Trial in Palo Alto (Utomilumab, Trastuzumab,

Completed
  • HER2 Positive Breast Carcinoma
  • +6 more
  • Palo Alto, California
    Stanford University, School of Medicine
Sep 22, 2022

Breast Cancer Trial in Guangzhou (GB221, Herceptin)

Completed
  • Breast Cancer
  • Guangzhou, Guangzhou, China
    The Fifth Affiliated Hospital of Guangzhou Medical University
May 25, 2021

Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma, Stage III Major Salivary Gland Cancer AJCC v8 Trial

Recruiting
  • Metastatic Salivary Gland Carcinoma
  • +4 more
  • New York, New York
    Memorial Sloane Kettering Cancer Center
Jan 11, 2023

Metastatic Lung Non-Small Cell Carcinoma, Refractory Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer American Joint

Recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +4 more
  • Necitumumab
  • +4 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Jan 5, 2023

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Malignant Tumor in the Brain Trial in Duarte

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Copper Cu 64-DOTA-Trastuzumab
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Nov 22, 2022

HER2-positive Breast Cancer Trial in Shanghai (SYSA1901, Pertuzumab, Trastuzumab)

Recruiting
  • HER2-positive Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Feb 8, 2023

Advanced Breast Cancer Trial in Spain (Olaparib [Lynparza®] plus Trastuzumab [Herceptin®])

Terminated
  • Advanced Breast Cancer
  • Olaparib [Lynparza®] plus Trastuzumab [Herceptin®]
  • Barcelona, Spain
  • +16 more
Jan 18, 2023

Breast Cancer, Tumor Metastasis Trial in Houston (Trastuzumab, RAD001)

Completed
  • Breast Cancer
  • Neoplasm Metastasis
  • Houston, Texas
    UT MD Anderson Cancer Center
Sep 30, 2022

HER2-positive Breast Cancer Trial in Tampa (Dendritic Cell (DC1) Vaccine, Trastuzumab, Pepinemab)

Recruiting
  • HER2-positive Breast Cancer
  • Dendritic Cell (DC1) Vaccine
  • +3 more
  • Tampa, Florida
    Moffitt Cancer Center
Dec 28, 2022

Breast Cancer Trial in Houston (Durvalumab, Trastuzumab, Pertuzumab)

Recruiting
  • Breast Cancer
  • Houston, Texas
    Houston Methodist Cancer Center
Aug 5, 2022

Breast Cancer Trial in Sweden (Trastuzumab deruxtecan, Docetaxel, Paclitaxel)

Not yet recruiting
  • Breast Cancer
  • Trastuzumab deruxtecan
  • +9 more
  • Malmö, Sweden
  • +6 more
Jun 8, 2023

HER2-positive Breast Cancer Trial in Tampa (biological, drug, procedure)

Recruiting
  • HER2-positive Breast Cancer
  • HER-2 pulsed DC1
  • +4 more
  • Tampa, Florida
    Moffitt Cancer Center
Oct 6, 2022